Bharat Biotech
Indian multinational biotechnology company and vaccine manufacturer
Bharat Biotech ▸ Facts ▸ Comments ▸ News ▸ Videos
Bharat Biotech International Limited (BBIL) is an Indian multinational biotechnology company based in Hyderabad, which is engaged in drug discovery, drug development, and the manufacture of vaccines, biotherapeutics, pharmaceuticals and healthcare products.
| 0 shares | ShareTweetSavePostSend |
You Might Like
Bharat Biotech arm Biovet gets CDSCO nod for lumpy skin disease vax for cattleBiovet, part of Bharat Biotech, has received approval from the CDSCO for its innovative lumpy skin disease vaccine, BIOLUMPIVAXIN, for dairy cattle and buffaloes. The vaccine, developed using a strain..IndiaTimes - Published | |
Covaxin had much lower adverse effects and overall favourable short-term safety profile in adolescents: StudyBharat Biotech’s indigenously developed Covid-19 vaccine Covaxin was overall found to have “much lower” AEFI (adverse effects following immunisation) rates in adolescents with a favourable..IndiaTimes - Published | |
Over 30% Covaxin takers suffered from health issues after 1 year: ReportA study from BHU analyzing the lasting impacts of Bharat Biotech's Covaxin found nearly a third of recipients reported adverse events of special interest (AESI). Among 926 participants, viral upper..IndiaTimes - Published | |
'Safety first', says Bharat Biotech amid AstraZeneca rowIndiaTimes - Published | |
Bharat Biotech begins clinical trials of more effective TB vaccine in IndiaIndiaTimes - Published | |
All Covid strains given to Bharat Biotech for a universal jab: CentreIndian Council of Medical Research (ICMR) has transferred all existing strains of variants of concern of SARS-CoV-2 - virus that causes Covid-19 - to Bharat Biotech Ltd for developing a universal Covid..IndiaTimes - Published | |
Covovax for adults to reach metros in a week: SIISerum Institute of India’s CEO Adar Poonawalla told TOI on Friday that doses of Covovax — Covid booster shot for adults — would reach major cities in four to five days, while a Bharat Biotech..IndiaTimes - Published | |
Covid-19: Health Minister launches Bharat Biotech's first India-made nasal vaccine, all you need to knowThe first nasal Covid-19 vaccine developed in India by Bharat Biotech, iNCOVACC launches on the 74th Republic Day.DNA - Published | |
Centre launches Bharat Biotech's iNCOVACC, India's first nasal Covid vaccineOn the occasion of Republic Day, India got its first-ever intranasal vaccine iNCOVACC, which will be manufactured by Hyderabad-based Bharat Biotech.The vaccine, dubbed "game changer" by some experts,..IndiaTimes - Published | |
India gets first nasal Covid vaccine: How it can be the 'game changer'Centre on Thursday launched India's first nasal Covid-19 vaccine iNCOVACC. Bharat Biotech's Incovacc received government approval for use as a booster dose in the country-wide mass inouclation program...IndiaTimes - Published | |
Covid-19: Bharat Biotech's iNCOVACC nasal vaccine to hit markets from February; know prices, eligibilityBharat Biotech's iNCOVACC will be the country of India's first needleless booster shot which will be available in private hospitals.DNA - Published | |
First nasal vaccine for Covid-19, Bharat Biotech's iNCOVACC, to be launched on January 26Bharat Biotech will offer the intranasal vaccine for Rs 325 to the government and Rs 800 to private hospitals.DNA - Published | |
First Indian intranasal Covid vaccine to be launched on January 26Homegrown vaccine maker Bharat Biotech will launch its intranasal Covid-19 vaccine iNCOVACC, the first of its kind in India, on January 26, the company's chairman and managing director Krishna Ella..IndiaTimes - Published | Ocugen-Bharat Biotech Covid vaccine Covaxin meets main goals in US trialOcugen Inc said on Monday the Covid-19 vaccine developed by its Indian partner Bharat Biotech International Ltd met the main goals of a trial in the United States. The vaccine, sold under brand name..IndiaTimes - Published |
